Liver and rheumatism;Leber und Rheuma

Zeitschrift fur Rheumatologie

Volumn 64, Issue 1, 2005, Pages 26-31

  Wiegard, C ^a   Lohse, A W ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Autoimmune hepatitis; Liver; Rheumatic diseases; Viral hepatitis

Indexed keywords

ALPHA INTERFERON; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; INTERFERON; LAMIVUDINE; LEFLUNOMIDE; LIVER ENZYME; METHOTREXATE; STEROID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACCIDENT; ALCOHOLISM; ALLERGY; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTHRITIS; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; BUDD CHIARI SYNDROME; CLINICAL FEATURE; CRYOGLOBULINEMIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EXPERIMENT; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER DISEASE; LIVER TOXICITY; MORBIDITY; MORPHOLOGY; PATIENT CARE; POLYARTERITIS; POLYARTERITIS NODOSA; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; PSORIATIC ARTHRITIS; PYODERMA GANGRENOSUM; RELAPSE; REVIEW; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK FACTOR; SCREENING; SJOEGREN SYNDROME; STEROID THERAPY; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXICITY; TREATMENT INDICATION; VASCULITIS; VIRUS; VIRUS REPLICATION;

ANTIRHEUMATIC AGENTS; HUMANS; LIVER DISEASES; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RHEUMATIC DISEASES; TREATMENT OUTCOME;

EID: 16844375850     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-005-0701-0     Document Type: Review

References (28)

1. Avsar E, Savas B, Tözün N, Ulusoy NB, Kalayci C (1998) Successful treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha as first line therapy. J Hepatol 28:525-526
2. Bennett RM (1993) Mixed connective tissue disease and other overlap syndromes. In: Kelley WN, Harris ED, Ruddy S, Sledge CB (eds) Textbook of Rheumatology. Philadelphia, WB Saunders Co, p 1058
3. Cacoub P, Lidove O, Maisonobe, Duhaut P, Thibault V, Ghillani P, Myers RP, Leger JM, Servan J, Piette JC (2002) Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 46(12):3317-3326
4. Cantor H, Dumont A (1969) Hepatic suppression of sensitization to antigen absorbed into the portal system. Nature 223:472-476
5. Cooksley WG, Piratvisuth T, Lee SD, Mahachai V, Chao YC, Tanwandee T, Chutaputti A, Gang WY, Zahm FE, Pluck N (2003) Peginterferon alpha-2 (40 kDa): an advance in the treatment of hepatitis B antigen-positive chronic hepatitis B. J Viral Hepat 10(4):298-305
6. Cornberg M, Hüppe D, Wiegand J, Felten G, Wedemeyer H, Manns MP (2003) Treatment of chronic hepatitis C with PEG-Interferon alpha-2b and Ribavirin: 24 weeks of therapy are sufficient for HCV genotype 2 and 3 Z Gastroenterol 41:517-522
7. Fried MW, Shiffamnn ML, Reddy KR (2002) Peginterferon alpha-2b plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347:975-982
8. Gow PJ, Fleming KA, Chapman RW (2001) Primary sclerosing cholangitis associated with rheumatoid arthritis and HLA DR4: is the association a marker of patients with progressive liver disease? J Hepatol 34(4):631-635
9. Hamilton E, Williams R, Barlow KA (1968) The arthropathy of idiopathic haemochromatosis. Q J Med 37:171
10. Iwai M, Harada Y, Ishii M, Tanaka S, Nakashima T, Okanoue T, Hirohata S (2003) Autoimmune hepatitis in a patient with systemic lupus erythematosus. Clin Rheumatol 22:234-236
11. Janssen HLA, Zonneveld, M van, Nunen AB van, Niesters HGM, Schalm SW, Man RA (2004) Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome. European Journal of Gastroenterology & Hepatology 16:801-807
12. Jordan JM (2004) Arthritis in hemochromatosis or iron storage disease. Curr Opin Rheumatol 16(1):62-66
13. Kadar J, Petrovicz E (2004) Adult-onset Still's disease. Best Pract Clin Rheumatol 18(5):663-676
14. Kremer JM, Koff R (1992) A debate: should patients with rheumatoid arthritis on methotrexate undergo liver biopsie? Semin Arthr Rheum 21:376
15. Lohse AW (2003) Autoimmune Lebererkrankungen. J of Laboratory Medicine 27(5/6):207-209
16. Michalak T (1978) Immune complexes of hepatitis B surface antigen in the pathogenesis of periarteritis nodosa. Am J Pathol 90:619
17. Millan-Mon A, Porto JL, Novo C (1993) Hepatic infarction in a pregnant patient with the primary antiphospholipid syndrome. Lupus 2:275
18. Naarendorp M, Kallemuchikkal U, Nuovo GJ, Gorevic PD (2001) Long-term efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection. J Rheumatol 28(11):2466-2473
19. O'Connor N, Dargan PI, Jones AL (2003) Hepatocellular damage from non-steroidal anti-inflammatory drugs. QJM 96(11):787-791
20. Perry MC (1992) Chemotherapeutic agents and hepatotoxicity. Semin Oncol 19:551
21. Seckin D, Durusoy C, Sahin S (2004) Concomitant vitiligo and psoriasis in a patient with interferon alfa-2a for chronic hepatitis B infection. Pediatr Dermatol 21(5):577-579
22. Sene D, Limal N, Cacoub P (2004) Hepatitis C virus-associated extrahepatic manifestations: a review. Metab Brain Dis 19(3-4):357-381
23. Snover D (1992) Biopsy diagnosis of Liver Disease. Baltimore, Williams and Wilkins, p 211
24. Tojo J, Ohira H, Abe K, Yokokawa J, Takiguchi J, Rai T, Shishido S, Sato Y, Kasukawa R (2004) Autoimmune hepatitis accompanied by systemic lupus erythematosus. Intern Med 43(3):258-262
25. Tsianos EV, Hoofnagle JH, Foc CPH (1989) Sjögreris syndrome in patients with primary biliary cirrhosis. Hepatology 11:730
26. Van Hoek B (1996) The spectrum of liver disease in systemic lupus erythematosus. Nether J Med 46:244-253
27. Wanless IR, Godwin TA, Allen F, Feder A (1980) Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. Medicine 59:367
28. Willis G, Scott DG, Jennings BA, Smith K, Bukhari M, Wimperis JZ (2002) HFE mutations in an inflammatory arthritis population. Rheumatology 41(2):176-179